The consensus price target hints at a 156.1% upside potential for Beyond (BYON). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Predict a 156.09% Upside in Beyond (BYON): Here's What You Should Know

The mean of analysts' price targets for Ardent Health Partners, Inc. (ARDT) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Predict a 36.55% Upside in Ardent Health Partners, Inc. (ARDT): Here's What You Should Know

How Much Upside is Left in Clearfield (CLFD)? Wall Street Analysts Think 26.51% — Positive

CLFD   Zacks Investment Research — May 13, 2025

The mean of analysts' price targets for Clearfield (CLFD) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news How Much Upside is Left in Clearfield (CLFD)? Wall Street Analysts Think 26.51%

The average of price targets set by Wall Street analysts indicates a potential upside of 102.9% in ClearPoint Neuro (CLPT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade

The consensus price target hints at a 224.4% upside potential for Cogent Biosciences (COGT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade

The consensus price target hints at a 35% upside potential for Easterly Government Properties (DEA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Can Easterly Government Properties (DEA) Climb 35.04% to Reach the Level Wall Street Analysts Expect?

Wall Street Analysts Believe Intapp (INTA) Could Rally 26.09%: Here's is How to Trade — Positive

INTA   Zacks Investment Research — May 13, 2025

The mean of analysts' price targets for Intapp (INTA) points to a 26.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Believe Intapp (INTA) Could Rally 26.09%: Here's is How to Trade

Can Honest (HNST) Climb 40.83% to Reach the Level Wall Street Analysts Expect? — Positive

HNST   Zacks Investment Research — May 13, 2025

The mean of analysts' price targets for Honest (HNST) points to a 40.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Can Honest (HNST) Climb 40.83% to Reach the Level Wall Street Analysts Expect?

Does Kemper (KMPR) Have the Potential to Rally 25.46% as Wall Street Analysts Expect? — Positive

KMPR   Zacks Investment Research — May 13, 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Kemper (KMPR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Does Kemper (KMPR) Have the Potential to Rally 25.46% as Wall Street Analysts Expect?

The mean of analysts' price targets for Mind Medicine MindMed (MNMD) points to a 279.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?

The mean of analysts' price targets for Centrus Energy (LEU) points to a 56.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Think Centrus Energy (LEU) Could Surge 56.61%: Read This Before Placing a Bet

Wall Street Analysts Believe 10x Genomics (TXG) Could Rally 55.85%: Here's is How to Trade — Positive

TXG   Zacks Investment Research — May 13, 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Believe 10x Genomics (TXG) Could Rally 55.85%: Here's is How to Trade

The consensus price target hints at a 51.8% upside potential for Inspired Entertainment (INSE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts See a 51.77% Upside in Inspired Entertainment (INSE): Can the Stock Really Move This High?

The consensus price target hints at a 258.5% upside potential for Tectonic Therapeutic, Inc. (TECX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts See a 258.52% Upside in Tectonic Therapeutic, Inc. (TECX): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in Treace Medical Concepts (TMCI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts See a 41.11% Upside in Treace Medical Concepts (TMCI): Can the Stock Really Move This High?

How Much Upside is Left in Spyre Therapeutics (SYRE)? Wall Street Analysts Think 258.34% — Positive

SYRE   Zacks Investment Research — May 13, 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 258.3% in Spyre Therapeutics (SYRE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news How Much Upside is Left in Spyre Therapeutics (SYRE)? Wall Street Analysts Think 258.34%

UPST vs. AFRM: Which AI-Powered Fintech Stock Offers Better Growth? — Neutral

AFRM  UPST   Zacks Investment Research — May 13, 2025

Which AI-powered fintech stock, Upstart Holdings or Affirm Holdings, offers the better investment opportunity at present? Let's find out.

image for news UPST vs. AFRM: Which AI-Powered Fintech Stock Offers Better Growth?

Paul Powers says we're just seeing the start of A.I. integration into cybersecurity.

image for news PANW, CRWD & Cybersecurity: "We're at the Starting Line" of A.I. Security Race

Plug Power Q1 Loss Wider Than Expected, Revenues Beat Estimates — Positive

PLUG   Zacks Investment Research — May 13, 2025

PLUG posts first-quarter 2025 results, wherein its revenues increase 11.1% year over year on growing electrolyzer deliveries and continued demand in material handling.

image for news Plug Power Q1 Loss Wider Than Expected, Revenues Beat Estimates

Where Food Comes From Q1 Profit Falls Amid Beef Market Headwinds — Negative

WFCF   Zacks Investment Research — May 13, 2025

WFCF posts lower Q1 earnings as beef market woes and avian flu weigh on revenues. Management highlights growth in retail labeling and upcycling.

image for news Where Food Comes From Q1 Profit Falls Amid Beef Market Headwinds